Stock prices for the maker of Tylenol plummeted on Friday following a report that indicated the common painkiller is going to be cited as a cause of autism in Health and Human Services Secretary Robert F. Kennedy Jr.’s report, which is anticipated this month.

Stock prices for Kenvue, the pharmaceutical company that makes acetaminophen by the brand name Tylenol, fell by more than 12% within half an hour of an article citing people familiar with Kennedy’s report published in the Wall Street Journal on Friday afternoon.

Recommended Stories

Hochul signs pro-COVID-19 vaccine executive order amid skepticism under RFK Jr.’s HHS

Biden undergoes surgery on forehead to remove skin cancer lesions

Top moments from RFK Jr.'s heated testimony on vaccines and public health

Buzz about Tyle

See Full Page